Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 128.22-6.71-52.3565.67-8.91

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is 128.22 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024128.22
Mar2023-6.71
Mar2022-52.35
Mar202165.67
Mar2020-8.91

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35
Negative
Mar2021 65.67
Positive
Mar2020 -8.91 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹148.5 Cr -0.9% -4.8% 18.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,342.0 Cr 3.4% 1.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹164,555.0 Cr 2.4% 3.2% 11.9% Stock Analytics
CIPLA ₹127,259.0 Cr 1.8% 1.9% -5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,898.0 Cr 2.8% -0.9% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,394.0 Cr 1.7% 6.2% -0.3% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

-0.9%

-4.8%

18.1%

SENSEX

0.9%

1.2%

-0.4%


You may also like the below Video Courses